Pathology, diagnostics, and classification of medulloblastoma

Volume: 30, Issue: 3, Pages: 664 - 678
Published: May 1, 2020
Abstract
Medulloblastoma (MB) is the most common CNS embryonal tumor. While the overall cure rate is around 70%, patients with high-risk disease continue to have poor outcome and experience long-term morbidity. MB is among the tumors for which diagnosis, risk stratification, and clinical management has shown the most rapid advancement. These advances are largely due to technological improvements in diagnosis and risk stratification which now integrate...
Paper Details
Title
Pathology, diagnostics, and classification of medulloblastoma
Published Date
May 1, 2020
Volume
30
Issue
3
Pages
664 - 678
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.